NIH-funded research R01 grant

Intravenous oxygen for cardiac arrest

Official title: Intravenous oxygen for the treatment of cardiac arrest

Funded at Boston Children's Hospital · NIH-11333296 · Data updated 2026-11-12

This project tests whether tiny oxygen-filled particles given through a vein can quickly raise oxygen levels during cardiac arrest to help people survive and reduce brain injury.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 21, 2025
Project endMarch 31, 2029
Funding year2026
Award (this year)$859,295
NIH project number5R01HL178815-02
Project IDNIH-11333296 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people experiencing in-hospital or out-of-hospital cardiac arrest, particularly when conventional ventilation fails to restore oxygen levels.

Less likely to help

Patients whose cardiac arrest is not driven by severe hypoxemia or who are beyond the time window for effective resuscitation may not receive benefit from this therapy.

What this research studies

If someone has cardiac arrest, researchers are developing tiny oxygen-filled particles that can be injected into a vein to deliver oxygen directly into the bloodstream. The particles are pH-sensitive polymer microbubbles that hold a high concentration of oxygen and are designed to dissolve safely after releasing their gas. In realistic pig models of asphyxia cardiac arrest, small doses of these microbubbles improved oxygenation during resuscitation, and the team will refine dosing and safety. The goal is to advance the approach toward use in hospitals and emergency care for people who cannot be oxygenated by standard methods.

Why it matters

Potential benefit: If successful, this approach could rapidly boost oxygen during cardiac arrest, improving chances of survival and reducing neurologic damage.

How similar studies have gone: This is a novel delivery method: preclinical animal studies (swine) showed improved oxygenation with these microbubbles, but human use remains largely untested.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Peng, Yifeng — Boston Children's Hospital
  • Study coordinator: Peng, Yifeng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.